Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6561 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Assessment of Outcomes Associated 

with the Preventive Health and Health 

Services Block Grant—Extension— 

Center for State, Tribal, Local and 

Territorial Support (CSTLTS), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

For more than 35 years, the 

Preventive Health and Health Services 

Block Grant (PHHS Block Grant) has 

provided flexible funding for all 50 

states, the District of Columbia, two 

American Indian tribes, five U.S. 

territories, and three freely associated 

states to address the unique public 

health needs of their jurisdictions in 

innovative and locally defined ways. 

First authorized by Congress in 1981 

through the Public Health Service Act 

(Pub. L. 102–531), the fundamental and 

enduring purpose of the grant has been 

to provide grantees with flexibility and 

control to address their priority public 

health needs. In 1992, Congress 

amended the law to align PHHS Block 

Grant funding priorities with the 22 

chapters specified in Healthy People 

(HP) 2000, a set of national objectives 

designed to guide health promotion and 

disease prevention efforts. Additional 

amendments included set-aside funds 

specifically dedicated to sex offense 

prevention and victim services, thus 

requiring grantees receiving this support 

to include related HP objectives and 

activities as part of their PHHS Block 

Grant—funded local programs. 

CDC is establishing a comprehensive, 

standardized method to collect data to 

describe select outputs and outcomes 

and ensure the accountability of the 

PHHS Block Grant. The CDC PHHS 

Block Grant Measurement Framework is 

an innovative approach to assessing 

cross-cutting outputs and outcomes 

resulting from grantees’ use of flexible 

grant funds. The framework defines 

measures that enable CDC to 

standardize the collection of data on 

grantee achievements. The CDC PHHS 

Block Grant Measurement Framework is 

an innovative approach to: Collecting 

data on public health infrastructure (i.e., 

information systems, quality 

improvement, efficiency and 

effectiveness of programs, services, and 

operations); addressing emerging public 

health needs; and implementing 

evidence-based public health 

interventions. 

The purpose of this information 

collection request (ICR) is to collect data 

that assess select cross-cutting outputs 

and outcomes of the grant (as defined by 

the framework measures) and that 

demonstrate the utility of the grant on 

a national level. This data collection 

will describe the outcomes of the PHHS 

Block Grant as a whole, rather than 

individual grantee activities or 

outcomes. Findings from this data 

collection will be used to: (1) Describe 

the outcomes and achievements of 

grantees’ public health efforts and 

identify how the use of PHHS Block 

Grant funds contributed to those results, 

and (2) help assess how the PHHS Block 

Grant advances work of the public 

health system and provides evidence to 

support future budgetary requests. 

The respondent universe consists of 

61 PHHS Block Grant coordinators, or 

their designees, across 61 health 

departments (50 states, the District of 

Columbia, two tribes, five U.S. 

territories, and three freely associated 

states). The assessment will be 

administered to PHHS Block Grant 

coordinators electronically via a webbased questionnaire. A link to the 

assessment will be provided by email 

invitation. The survey will be 

completed once every two years. The 

total annualized estimated burden is 46 

hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

PHHS Block Grant Coordinators, or 

Designees.

PHHS Block Grant Assessment ...... 61 1 45/60 46 

Total ........................................... ........................................................... ........................ ........................ ........................ 46 

Jeffery M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–02403 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

National Lung Hospital (NLH)/National 

Tuberculosis Program, Vietnam 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $1,500,000, for 

Year 1 of funding to the National Lung 

Hospital (NLH)/National Tuberculosis 

Program (NTP). The award will support 

high quality TB, multi-drug resistant TB 

(MDR–TB), and TB/HIV programs to 

strengthen and expand TB and MDR–TB 

quality-assured diagnostic capacity 


lotter on DSK11XQN23PROD with NOTICES1
6562 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 

(clinical and laboratory testing); 

promote TB, MDR–TB, and TB/HIV 

prevention and integration into existing 

healthcare services; strengthen TB 

surveillance and monitoring and 

evaluation (M&E) and improve 

collaboration and coordination between 

TB and other programs, particularly HIV 

and COVID–19. Funding amounts for 

years 2–5 will be set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Amy Bailey, Center for Global Health, 

Centers for Disease Control and 

Prevention, 5th/Floor Tung Shing 

Building, No 2, Ngo Quyen Street, Hoan 

Kiem District Hanoi, Vietnam, 

Telephone: 800–232–6348, email: fue8@

cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will contribute to 

enhancing early and universal access to 

high quality prevention, diagnosis, and 

treatment services for TB, MDR–TB, and 

TB/HIV with the goal of ending TB in 

Vietnam by 2030. 

The NLH/NTP is in a unique position 

to conduct this work as it is mandated 

by Vietnam Ministry of Health (MoH) 

with oversight and implementation of 

TB prevention and control activities in 

Vietnam. The NLH is the leading 

tertiary hospital in charge of 

examination and treatment of TB and 

lung diseases and steering TB and lung 

disease prevention and control activities 

throughout the country. 

Summary of the Award 

Recipient: National Lung Hospital 

(NLH)/National Tuberculosis Program 

(NTP). 

Purpose of the Award: The purpose of 

this award is to support high quality TB, 

MDR–TB, and TB/HIV programs to 

strengthen and expand TB and MDR–TB 

quality-assured diagnostic capacity 

(clinical and laboratory testing); 

promote TB, MDR–TB, and TB/HIV 

prevention and integration into existing 

healthcare services; strengthen TB 

surveillance and M&E and improve 

collaboration and coordination between 

TB and other programs, particularly HIV 

and COVID–19. 

Amount of Award: The approximate 

year 1 funding amount will be 

$1,500,000 in Federal Fiscal Year (FYY) 

2022 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 1, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–02412 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP); 

SIP22–001, Process, Outcome, and Cost 

Evaluation of Free Sunscreen 

Dispensers in Outdoor Community 

Settings. 

Date: April 26, 2022. 

Time: 11:00 a.m.–6:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman Ph.D., Scientific Review Officer, 

National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 

4770 Buford Highway, Mailstop S107– 

B, Atlanta, Georgia 30341, Telephone: 

(770) 488–6511, Email: JRaman@

cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–02381 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP): 

RFA–PS–22–001, Implementing Preexposure Prophylaxis for HIV 

Prevention in Syringe Service Programs; 

RFA–PS–22–002, Implementation 

Research on Telehealth Strategies to 

Support Retention in Care and 

Treatment among Antiretroviral 

Therapy (ART) Patients and Preexposure Prophylaxis (PrEP) Clients; 

and RFA–PS–22–004, Understanding 

HIV/STD Risk and Enhancing PrEP 

Implementation Messaging in a Diverse 

Community-Based Sample of Gay, 

Bisexual, and Other Men Who Have Sex 

with Men in a Transformational Era. 

Date: March 30, 2022. 

Time: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, 1600 Clifton Road, 

NE, Mailstop US8–1, Atlanta, Georgia 


lotter on DSK11XQN23PROD with NOTICES1